Cambridge Financial Group, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001334199

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHigh Turnover how tags are computed

Q3 2026 · 32 positions · Total reported value $273.00M · Top-10 concentration 42.0% · Updated 2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

Turnover: 73.5% · 1 new · 22 cut · 2 exited

Active Share (vs S&P 500): 80.4% · vs QQQ: 84.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +3.6% · vs SPY +1.4% · Prev Value $287.38M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.5% · vs SPY +0.3% · Latest Value $273.00M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Cambridge Financial Group, Inc. disclosed 32 equity positions with a combined reported value of $273.00M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 42.0% of reported value. HoldingsHub classifies the profile as Small / High Turnover.

The largest disclosed positions as of Q3 2026 were AVGO ($13.00M), VLO ($12.79M), MSFT ($11.82M). By sector, the heaviest allocations are Technology 28.0%, Consumer Discretionary 23.4%. Versus the prior quarter, allocation shifted toward Consumer Staples (+3.2pp), Energy (+1.6pp) and away from Utilities (-3.5pp), Consumer Discretionary (-3.6pp).

Versus the prior quarter, Cambridge Financial Group, Inc. opened 1 new positions, trimmed 22 and fully exited 2, a turnover rate of 73.5% of positions. The portfolio's overlap with the prior quarter was 91% of names.

The largest new positions opened in Q3 2026 were CVS ($6.49M).

Of the 2 positions fully exited versus the prior quarter, the largest were OKE ($9.96M), MCD ($7.35M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • CVS CVS HEALTH CORP · $6.49M

Fully Exited (vs previous quarter)

  • OKE ONEOK INC NEW · prev qtr: $9.96M
  • MCD MCDONALDS CORP · prev qtr: $7.35M

Insider Transactions (Form 4)

Latest Cambridge Financial Group, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Cambridge Financial Group, Inc. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 33 positions worth $287.38M in total. HoldingsHub carries 10 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $287.38M reported value (Q2 2026)
  • Top 10 holdings = 39.4% of reported value
  • Largest position: AVGO (BROADCOM INC) at 4.9%
  • Average position size: $8.71M

Sector Tilt

  • Information Technology 27.2%
  • Consumer Discretionary 27.0%
  • Financials 13.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 10 added, 15 reduced, 1 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced positions across most top-10 holdings (9/10), suggesting a cautious or profit-taking stance, with only Cencora (COR) added. Heavy reductions in energy (VLO) and tech (AVGO, MSFT, NVDA) indicate potential rotation or risk aversion. 2. Key moves: - Reduced: Broadcom (AVGO, -1.1% shares), Valero (VLO, -4.3%), Microsoft (MSFT, -2.6%), Arista (ANET, -4.6%), Cardinal Health (CAH, -1.6%), Apple (AAPL, -3.5%), Target (TGT, -2.9%), Nvidia (NVDA, -3.1%), Texas Instruments (TXN, -16.7%). - Added: Cencora (COR, +3.0% shares). 3. Portfolio structure: Active management (frequent rebalancing), tech-heavy (6/10 top holdings), with modest healthcare (2/10) and energy (1/10) exposure. High turnover (32 positions, 1 new) suggests tactical adjustments. 4. Per-holding one-liner: - AVGO: Semiconductor chips (Broadcom). - VLO: Oil refining (Valero Energy). - MSFT: Cloud/software (Microsoft). - ANET: Network switches (Arista). - CAH: Medical supplies (Cardinal Health). - AAPL: Consumer electronics (Apple). - TGT: Retail (Target). - COR: Drug distribution (Cencora). - NVDA: GPUs/AI (Nvidia). - TXN: Semiconductors (Texas Instruments). 5. Style summary: Actively managed, tech-focused fund tactically reducing cyclicals/tech while adding healthcare, signaling cautious rotation.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-13 03:29

Sector Allocation

Technology 28.0%
Financials 13.2%
Health Care 11.7%
Utilities 6.3%
Energy 4.7%
Other 2.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 37.03K $13.00M 4.76%
4.76%
Reduce
2 33.00K $12.79M 4.69%
4.69%
Reduce
3 23.05K $11.82M 4.33%
4.33%
Reduce
4 56.34K $11.47M 4.20%
4.20%
Reduce
5 51.49K $11.46M 4.20%
4.20%
Reduce
6 33.52K $11.16M 4.09%
4.09%
Reduce
7 70.76K $11.09M 4.06%
4.06%
Reduce
8 36.34K $10.91M 4.00%
4.00%
Add
9 46.81K $10.69M 3.92%
3.92%
Reduce
10 36.53K $10.23M 3.75%
3.75%
Reduce
11 323.49K $9.76M 3.57%
3.57%
Reduce
12 36.80K $9.63M 3.53%
3.53%
Reduce
13 108.28K $9.56M 3.50%
3.50%
Reduce
14 41.58K $9.47M 3.47%
3.47%
Reduce
15 160.97K $9.44M 3.46%
3.46%
Add
16 172.86K $9.41M 3.45%
3.45%
Reduce
17 71.62K $9.27M 3.40%
3.40%
Reduce
18 21.39K $9.19M 3.37%
3.37%
Reduce
19 114.17K $8.90M 3.26%
3.26%
Hold
20 32.27K $8.72M 3.19%
3.19%
Reduce
21 125.66K $8.54M 3.13%
3.13%
Reduce
22 63.17K $8.36M 3.06%
3.06%
Add
23 25.34K $7.91M 2.90%
2.90%
Reduce
24 184.45K $7.68M 2.81%
2.81%
Reduce
25 107.25K $7.61M 2.79%
2.79%
Add
26 25.07K $7.15M 2.62%
2.62%
Reduce
27 35.07K $6.52M 2.39%
2.39%
Add
28 75.69K $6.49M 2.38%
2.38%
New
29 2.58K $2.45M 0.90%
0.90%
Reduce
30 14.59K $1.60M 0.58%
0.58%
Add
31 905 $690.18K 0.25%
0.25%
Add
32 160 $33.28K 0.01%
0.01%
Hold

FAQ

What did Cambridge Financial Group, Inc. buy in 2026-Q3?

In its 2026-Q3 13F filing, Cambridge Financial Group, Inc. reported 32 equity positions worth $273.00M in aggregate; its largest disclosed positions were AVGO ($13.00M), VLO ($12.79M), MSFT ($11.82M).

How large is Cambridge Financial Group, Inc.'s portfolio?

Cambridge Financial Group, Inc. reported $273.00M of long equity holdings across 32 positions as of 2026-Q3. Top-10 holdings account for 42.0% of reported value.

What is Cambridge Financial Group, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cambridge-financial-2/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →